scholarly journals 3P120 Purification and crystallization of membrane bound nitric oxide reductase from Pseudomonas aeruginosa

2005 ◽  
Vol 45 (supplement) ◽  
pp. S233
Author(s):  
T. Hino ◽  
H. Kumita ◽  
Y. Fukumori ◽  
Y. Shiro
2006 ◽  
Vol 401 (1) ◽  
pp. 111-119 ◽  
Author(s):  
Faye H. Thorndycroft ◽  
Gareth Butland ◽  
David J. Richardson ◽  
Nicholas J. Watmough

A specific amperometric assay was developed for the membrane-bound NOR [NO (nitric oxide) reductase] from the model denitrifying bacterium Paracoccus denitrificans using its natural electron donor, pseudoazurin, as a co-substrate. The method allows the rapid and specific assay of NO reduction catalysed by recombinant NOR expressed in the cytoplasmic membranes of Escherichia coli. The effect on enzyme activity of substituting alanine, aspartate or glutamine for two highly conserved glutamate residues, which lie in a periplasmic facing loop between transmembrane helices III and IV in the catalytic subunit of NOR, was determined using this method. Three of the substitutions (E122A, E125A and E125D) lead to an almost complete loss of NOR activity. Some activity is retained when either Glu122 or Glu125 is substituted with a glutamine residue, but only replacement of Glu122 with an aspartate residue retains a high level of activity. These results are interpreted in terms of these residues forming the mouth of a channel that conducts substrate protons to the active site of NOR during turnover. This channel is also likely to be that responsible in the coupling of proton movement to electron transfer during the oxidation of fully reduced NOR with oxygen [U. Flock, N. J. Watmough and P. Ädelroth (2005) Biochemistry 44, 10711–10719].


2018 ◽  
Vol 1859 (5) ◽  
pp. 333-341 ◽  
Author(s):  
Raika Yamagiwa ◽  
Takuya Kurahashi ◽  
Mariko Takeda ◽  
Mayuho Adachi ◽  
Hiro Nakamura ◽  
...  

2001 ◽  
Vol 83 (4) ◽  
pp. 281-286 ◽  
Author(s):  
Shiniji Kurose ◽  
Nobuhiko Sakurai ◽  
Takeshi Sakurai

2017 ◽  
Vol 41 ◽  
pp. 67-81 ◽  
Author(s):  
Jonathan L. Robinson ◽  
Jacob M. Jaslove ◽  
Allison M. Murawski ◽  
Christopher H. Fazen ◽  
Mark P. Brynildsen

2007 ◽  
Vol 355 (2) ◽  
pp. 587-591 ◽  
Author(s):  
Kohei Kakishima ◽  
Akiko Shiratsuchi ◽  
Azuma Taoka ◽  
Yoshinobu Nakanishi ◽  
Yoshihiro Fukumori

2019 ◽  
Vol 75 (1) ◽  
pp. 117-125 ◽  
Author(s):  
Odel Soren ◽  
Ardeshir Rineh ◽  
Diogo G Silva ◽  
Yuming Cai ◽  
Robert P Howlin ◽  
...  

Abstract Objectives The cephalosporin nitric oxide (NO)-donor prodrug DEA-C3D (‘DiEthylAmin-Cephalosporin-3′-Diazeniumdiolate’) has been shown to initiate the dispersal of biofilms formed by the Pseudomonas aeruginosa laboratory strain PAO1. In this study, we investigated whether DEA-C3D disperses biofilms formed by clinical cystic fibrosis (CF) isolates of P. aeruginosa and its effect in combination with two antipseudomonal antibiotics, tobramycin and colistin, in vitro. Methods β-Lactamase-triggered release of NO from DEA-C3D was confirmed using a gas-phase chemiluminescence detector. MICs for P. aeruginosa clinical isolates were determined using the broth microdilution method. A crystal violet staining technique and confocal laser scanning microscopy were used to evaluate the effects of DEA-C3D on P. aeruginosa biofilms alone and in combination with tobramycin and colistin. Results DEA-C3D was confirmed to selectively release NO in response to contact with bacterial β-lactamase. Despite lacking direct, cephalosporin/β-lactam-based antibacterial activity, DEA-C3D was able to disperse biofilms formed by three P. aeruginosa clinical isolates. Confocal microscopy revealed that DEA-C3D in combination with tobramycin produces similar reductions in biofilm to DEA-C3D alone, whereas the combination with colistin causes near complete eradication of P. aeruginosa biofilms in vitro. Conclusions DEA-C3D is effective in dispersing biofilms formed by multiple clinical isolates of P. aeruginosa and could hold promise as a new adjunctive therapy to patients with CF.


Sign in / Sign up

Export Citation Format

Share Document